Last reviewed · How we verify
NCT03394040
Point-of-Use Pathogen Identification Tool for Diarrhea
trial in Diarrhea in 1,000 participants. Terminated before completion.
23 December 2019
Quick facts
| Lead sponsor | National Institute of Nursing Research (NINR) |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 14 February 2019 |
| Primary completion | 23 December 2019 |
| Estimated completion | 23 December 2019 |
| Sites | 1 location across United States |
Conditions studied
- Diarrhea — all drugs for Diarrhea →
Sponsor
National Institute of Nursing Research (NINR)
Who can join
Eligibility, any sex, with Diarrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Many people suffer from diarrhea every year. In the United States, it leads to about 130,000 hospitalizations and 3,000 deaths a year. Researchers want to test a tool that may show them what germs cause diarrhea. It is a simple paper strip test and doesn t require electric power. This may make it easier for health care workers to more quickly fight diarrheal diseases. Objective: To test a tool that may detect what germs cause diarrhea. Eligibility: People already enrolled in an active NIH protocol who have diarrhea Design: Participants will have 1 or 2 studies. They will give information about their symptoms, current medicines, and basic personal data. They will give a stool sample. Part of each sample will be tested in a lab. The rest will be stored indefinitely. No personal data will be connected to the samples. The stored samples may be used in future research. Positive test results will be reported to a participant s primary doctor
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03394040
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diarrhea
Currently open trials in the same condition.
- NCT07285785 — Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea · Phase 4 · recruiting
- NCT07385196 — Defining Ileorectal Syndrome: a Prospective Observational Study · recruiting
- NCT07205926 — First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Yo · Phase 1 · recruiting
- NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting
- NCT06801067 — A Study of SER-155 to Treat Diarrhea in People on Immunotherapy · Phase 1 · recruiting
Other National Institute of Nursing Research (NINR) trials
Trials by the same sponsor.
- NCT04141696 — A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue · Phase 1, PHASE2 · completed
- NCT04883359 — Immersive VR Environments to Induce and Evaluate Cognitive Fatigability · terminated
- NCT03998358 — Characterization of Fatigue in Military Personnel With Traumatic Brain Injuries · withdrawn
- NCT02931474 — Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and · Phase 2 · withdrawn
- NCT02379403 — Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Ol · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03394040 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Nursing Research (NINR)
- Last refreshed: 6 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03394040.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing